source
- Pharma companies push FDA for risk-based flexibility in container-closure testing guidanceMajor pharma firms have written to the FDA urging a shift in its current guidance on testing container-closure systems for drug and biologic products. They argue that a risk-based, flexible approa…
- NIH Scales Back Replication Initiative, Critics Warn It Undermines Scientific RigorNIH originally announced a push to make replication a core part of biomedical research, including an $850,000 Replication Prize launched in March 2025. Health secretary Robert F. Kennedy Jr. sugge…